• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM ASD OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE CARDIOFORM ASD OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Device Problems Difficult to Remove (1528); Material Separation (1562); Inadequacy of Device Shape and/or Size (1583); Migration (4003); Physical Resistance/Sticking (4012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/15/2021
Event Type  Injury  
Event Description
It was reported to gore a 32mm gore® cardioform asd occluder was selected to treat an atrial septal defect.The device was deployed; however, a small residual shunt was noted and the physician decided to remove the device.The physician states he was too aggressive when he felt resistance in attempting to remove the device and the retrieval cord broke.When attempting to retrieve the device by snare through a 14f sheath, it appeared that it was being pulled by only one wire and it looked like the device was coming apart.The device embolized into the left atrium and was then snared and removed without any harm to the patient.A second 32mm gore® cardioform asd occluder was successfully implanted.
 
Manufacturer Narrative
H6: updated investigation findings-code 213 the engineering evaluation revealed that the occluder wire frame was damaged and frame wires were exposed as received by gore.This can likely be attributed to the snaring process.If the occluder was not secured to the snare it is further possible for the occluder to release from the snare and embolize, as in this case.The size and shape of the occluder were unremarkable.The occluder eyelets were unremarkable (i.E.No exposed eyelet wires or insufficient eyelet trim).The delivery system and retrieval cord were not returned for analysis.It is possible that excessive force applied during device retrieval caused the retrieval cord to break.The cause of the residual shunt, difficulty retrieving the device, broken retrieval cord, and device embolism is unknown and cannot be determined from the evidence available.H6: updated investigation conclusions codes the gore® cardioform asd occluder instructions for use states: adverse events associated with the use of the occluder may include but are not limited to: device embolization.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE CARDIOFORM ASD OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11819214
MDR Text Key250443875
Report Number2017233-2021-01993
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/29/2021
Date Manufacturer Received04/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age4 YR
Patient Weight17
-
-